Apnimed
MA - Cambridge
BiotechnologyFocus: Sleep Apnea Drugs
Apnimed is a life sciences company focused on Sleep Apnea Drugs.
Metabolic Diseases
Funding Stage
PUBLIC
Open Jobs
0
Pipeline & Clinical Trials
STANDARDCARE
Obstructive Sleep ApneaClinical Trials (1)
NCT06525337Adherence to Health Coaching with Wearable Devices: Enhancing Patient Engagement and Outcomes
N/ASAS0421a
Sleep ApneaClinical Trials (1)
NCT03892772Combination Pharmacological Interventions for Multiple Mechanisms of Obstructive Sleep Apnea
Phase 1/2Dosing 1: Atomoxetine
Obstructive Sleep ApneaClinical Trials (1)
NCT05101122Study for Efficacy and Dose Escalation of AD313 + Atomoxetine (SEED)
Phase 1/2Phase 2
Clinical Trials (1)
NCT04445688Crossover Trial of AD036 in Obstructive Sleep Apnea
Phase 2Phase 2
Clinical Trials (1)
NCT04611750Pharmacological Intervention for Symptomatic Mild Sleep Disordered Breathing
Phase 2Phase 2
Clinical Trials (1)
NCT05448443Study of AD981 Versus Placebo in Obesity Hypoventilation Syndrome
Phase 2Period A
OSAClinical Trials (1)
NCT05793684AD816 Crossover Study
Phase 2Phase 2
Clinical Trials (1)
NCT04449133Study of AD128 Versus Placebo in Obstructive Sleep Apnea
Phase 2Sivopixant
Sleep ApneaClinical Trials (1)
NCT06776432Safety and Efficacy Study of Sivopixant, Acetazolamide and SASS-001 in Sleep Apnea
Phase 2Phase 2
Clinical Trials (1)
NCT04645524Crossover Trial of AD182 and AD504 in Obstructive Sleep Apnea
Phase 2AD036 Dose 1
Obstructive Sleep ApneaClinical Trials (1)
NCT03845023Trial of AD036 in Obstructive Sleep Apnea
Phase 2AD109 dose1- A
Obstructive Sleep ApneaClinical Trials (1)
NCT04631107AD109 Dose Finding in Mild to Moderate OSA
Phase 2Phase 2
Clinical Trials (1)
NCT04580394Crossover Trial of AD109 in Obstructive Sleep Apnea
Phase 2AD109
OSAClinical Trials (1)
NCT06400615Study That Tests AD109 in Patients Taking GLP-1 Drugs
Phase 2Phase 2
Clinical Trials (1)
NCT05071612Parallel Arm Trial of AD109 and AD504 In Patients With OSA
Phase 2Phase 2
Clinical Trials (1)
NCT04905979Trial of AD113 and Atomoxetine in OSA Patients With Hypertension
Phase 2Phase 2/3
Clinical Trials (1)
NCT04394143Effect of AD128 to Treat Obstructive Sleep Apnea
Phase 2/3AD109
OSAClinical Trials (1)
NCT05811247Parallel Arm Trial of AD109 and Placebo With Patients With OSA (LunAIRo)
Phase 3AD109
OSAClinical Trials (1)
NCT05813275Parallel-Arm Study to Compare AD109 to Placebo With Patients With OSA (SynAIRgy Study)
Phase 3Aroxybutynin and Atomoxetine
OSAClinical Trials (1)
NCT06566820Continuation Protocol for Obstructive Sleep Apnea (OSA)
Phase 3Open Jobs (0)
No open positions listed yet. Check their careers page directly.
Interview Prep Quick Facts
Portfolio: 20 clinical trials